The Unmistakable Creative Podcast Dylan Beynon: Building Mindbloom and the Science of Psychedelic-Assisted Therapy
10 snips
Nov 20, 2025 Dylan Beynon shares his journey of creating Mindbloom, a groundbreaking at-home ketamine therapy platform driven by personal tragedy. He discusses how psychedelics like ketamine foster neuroplasticity, enabling profound mental health transformations with better outcomes than traditional meds. Navigating historical stigmas and FDA regulations, Dylan advocates for therapeutic psychedelics' acceptance. He explains the impact of addiction, the need for destigmatization, and how telemedicine can democratize access to mental health treatments.
AI Snips
Chapters
Books
Transcript
Episode notes
Family Tragedy That Sparked A Mission
- Dylan Beynon grew up with a mother and sister who both had schizoaffective disorder and struggled with addiction.
- Both later died of fentanyl overdoses after years of homelessness and failed treatments, which motivated his work in mental health.
College Epiphany And Psychedelic Breakthrough
- Dylan discovered cognitive science and positive psychology in college and realized his pursuit of achievement left him unhappy.
- Psychedelics like MDMA and psilocybin catalyzed a personal transformation into greater empathy and well-being.
Combine Medicine With Guided Therapy
- Use a structured program: medical oversight, coaching, and guided sessions rather than just taking medicine alone.
- Combine psychiatric care, preparatory coaching, and integration to improve clinical outcomes over drug-only approaches.
